University of Oxford’s Ebola vaccine began human trials
On Nov. 11, 2021, the University of Oxford began recruiting for a Phase I trial to test an…
-
-
Zipline, Pfizer and BioNTech paved way for automated, on-demand delivery of first mRNA COVID-19 vaccines in Ghana
On Nov. 11, 2021, Zipline, Pfizer and BioNTech announced that Zipline had successfully completed the first long-range drone…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Vaccine | WHO
Global progress against measles threatened amidst COVID-19 pandemic
On Nov. 10, 2021, the World Health Organization (WHO) announced that while reported measles cases had fallen compared…
-
Meridian Bioscience received FDA Emergency Use Authorization for Revogeneﾮ SARS-CoV-2 molecular assay
On Nov. 10, 2021, Meridian Bioscience announced that their Revogeneﾮ SARS-CoV-2 assay was granted Emergency Use Authorization by…
-
Politicization and COVID-19 vaccine resistance in the U.S. widened during pandemic
On Nov. 10, 2021, a study by researchers at Georgia State University showed that the politicization of science…
-
Biden Administration invested $650 million in rapid diagnostic testing into increase access to tests
On Nov. 10, 2021, the Biden-Harris Administration announced that it was increasing access to COVID-19 testing for Americans…
-
Moderna filed to expand the conditional Marketing Authorization for COVID-19 vaccine in the EU to include children ages 6-11 years
On Nov. 9, 2021, Moderna announced that it has submitted for a variation to the conditional marketing authorization…
-
INOVIO received FDA authorization to proceed with INNOVATE phase 3 segment for COVID-19 vaccine candidate
On Nov. 9, 2021, Inovio Pharma announced that the U.S. Food and Drug Administration (FDA) provided authorization to…
-
Swedish announced transformational $20 million gift from late philanthropist Paul G. Allen
On Nov. 9, 2021, Swedish announced a $20 million personal bequest from the late philanthropist Paul G. Allen,…
-
Howard Hughes Medical Institute’ Codetta Program deciphered genetic code in 250,000 genomes
On Nov. 9, 2021, Howard Hughes Medical Institute announced a program, named Codetta, that can read the genome…
-
FDA authorized additional indication for BinaxNOW COVID-19 over-the-counter antigen test
On Nov. 8, 2021, The U.S. Food and Drug Administration (FDA) reissued the emergency use authorization (EUA) for…
-
Cocrystal Pharma’s SARS-CoV-2 protease inhibitors ddemonstrated pan-viral activity against human common Coronaviruses, Noroviruses, Rhinoviruses and Enteroviruses
On Nov. 8, 2021, Cocrystal Pharma announced that its SARS-CoV-2 main protease inhibitors showed potent in vitro pan-viral…
-
Phase 3 analyses showed that a single dose of REGEN-COV provides long-term protection against COVID-19
On Nov. 8, 2021, Regeneron announced that the European Commission had approved the casirivimab and imdevimab antibody cocktail,…
-
Amyris announced JV partnership with ImmunityBio for next generation COVID-19 RNA vaccine
On Nov. 8, 2021, Amyris announced announced it had entered into a 50:50 joint venture arrangement with ImmunityBio…
-
Ronapreve approved for additional indication as preventive treatment of symptomatic COVID-19 in Japan
On Nov. 5, 2021, Chugai Pharmaceutical, announced that it had obtained approval from the Ministry of Health, Labour…
-
Oxford University researchers uncovered gene that doubles risk of death from COVID-19
On Nov. 5, 2021, scientists at Oxford University announced they had identified the gene responsible for doubling the…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics | USDA | Vaccine | Veterinary
The USDA confirmed COVID-19 in Hyenas at a Colorado Zoo
On Nov. 5, 2021, the USDA’s (USDA) National Veterinary Services Laboratories announced confirmation of SARS-CoV-2 in two spotted…
-
NIH scientists identifed mechanism that may influence infectivity of SARS-CoV-2 variants
On Nov. 5, 2021, scientists at the National Institutes of Health announced they had found that a process…
-
Pfizer’s COVID-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis
On Nov. 5, 2021, Pfizer announced it was investigational novel COVID-19 oral antiviral candidate, PAXLOVID, significantly reduced hospitalization…
-
The FDA issued an emergency use authorization for the iHealth COVID-19 Antigen Rapid Test
On Nov. 5, 2021, the U.S. Food and Drug Administration The FDA issued an emergency use authorization (EUA)…
-
COVID-19 | Nanotechnology | Vaccine | WHO
Novavax filed COVID-19 vaccine for Emergency Use listing with World Health Organization
On Nov. 4, 2021, Novavax announced the completion of its rolling submission to the World Health Organization (WHO)…
-
INOVIO further expanded INNOVATE phase 3 trial for COVID-19 DNA vaccine candidate INO-4800 in India
On Nov. 3, 2021, Inovio Pharma announced that it had received authorization from India’s Central Drugs Standard Control…
-
Database lock completed for Innovation Pharmaceuticalsﾒ phase 2 clinical trial of brilacidin for COVID-19
On Nov. 3, 2021, Innovation Pharma announced that the Company had received confirmation that hard lock of the…
-
Resverlogix entered agreement with Supreme Council of Arab-African Economy for development of Apabetalone for COVID-19 patients
On Nov. 5, 2021, Resverlogix announced that it had entered into a cooperation agreement with the Supreme Council…
-
Novavax filed COVID-19 vaccine for provisional approval in New Zealand
On Nov. 3, 2021, Novavax announced the company had filed for provisional approval of the vaccine to the…
-
WHO issued emergency use listing for eighth COVID-19 vaccine
On Nov. 3, 2021, the World Health Organization (WHO) issued an emergency use listing (EUL) for COVAXINﾮ (developed…
-
U.S. FDA authorizd InteliSwabﾙ COVID-19 rapid tests for at-home testing for delta variant detection
On Nov. 2, 2021, OraSure Technologies announced that the EUA for its InteliSwabﾙ COVID-19 rapid tests had been…
-
NRx Pharmaceuticals announced favorable safety report for ZYESAMIﾮ (aviptadil) in critical care study in patients with COVID-19
On Nov. 5, 2021, NRx Pharmaceuticals reported a safety update on ZYESAMIﾮ (aviptadil), which was being tested in…
-
NIH announced study of long-term effects of COVID-19 in pregnancy
On Nov. 2, 2021, the National Institutes of Health announced support for a four-year follow-up study on the…
-
Novavax and Serum Institute of India receive Emergency Use Authorization for COVID-19 vaccine in Indonesia
On Nov. 1, 2021, Novavax and Serum Institute of India announced that the National Agency of Drug and…
